GLRX is a key regulator of immune response in glioma


  • The glutaredoxin gene GLRX plays an important role in the immune response of gliomas and may also serve as a prognostic indicator due to its suppressive effects on T-cell response.

Why this matters

  • Gliomas are mainly characterised by high rates of recurrence and poor survival outcomes, despite aggressive treatment.

  • Novel therapeutic targets and/or molecular-targeted drugs may hold promise in improving the prognosis of patients with gliomas.

  • Glutaredoxin, which is encoded by the GLRX gene, performs various biological functions in cancer, but it has not been studied in the context of glioma.